IBRUTINIB - ORAL
PHONETIC PRONUNCIATION: (eye-BROO-ti-nib)
COMMON BRAND NAME(S): Imbruvica
GENERIC NAME(S): ibrutinib
Uses
USES: This medication is used to treat certain cancers (such as mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).
How to use IBRUTINIB - ORAL
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start taking ibrutinib and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth with a full glass of water (8 ounces or 240 milliliters) as directed by your doctor, usually once daily. Swallow the capsules and tablets whole. Do not open, break, or chew the capsules. Do not cut, crush, or chew the tablets. Drink plenty of fluids while taking ibrutinib unless otherwise directed by your doctor. The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Do not increase your dose or take this medication more often than prescribed. Your condition will not improve any faster, and your risk of serious side effects will increase. Avoid eating grapefruit or drinking grapefruit juice while using this medication unless your doctor or pharmacist says you may do so safely. Also avoid eating Seville oranges (often found in marmalade). Grapefruit and Seville oranges can increase the chance of side effects with this medicine. Ask your doctor or pharmacist for more details. Since this drug can be absorbed through the skin and lungs and may harm an unborn baby, women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the capsules.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for IBRUTINIB - ORAL
Ibrutinib is an oral medication used for the treatment of certain types of cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), and Waldenström macroglobulinemia.
Ibrutinib works by blocking certain enzymes in cancer cells called Bruton's tyrosine kinase (BTK), which helps to slow down the growth and spread of cancer cells.
Ibrutinib is taken orally in the form of capsules or tablets, with or without food. The dosage and duration of treatment will vary depending on the specific cancer and individual patient factors, so it's important to follow the instructions provided by your doctor.
Common side effects of Ibrutinib may include diarrhea, nausea, vomiting, constipation, fatigue, muscle and joint pain, headache, rash, and bruising. It's important to report any severe or persistent side effects to your doctor.
Ibrutinib can interact with certain medications, including blood thinners, antiplatelet drugs, and strong CYP3A inhibitors or inducers. It's important to inform your doctor about all the medications you are taking, including prescription, over-the-counter, and herbal products.
The response to Ibrutinib can vary depending on the type and stage of cancer. It may take several weeks or months to see the full effects of the medication. Your doctor will monitor your progress through regular blood tests and imaging studies.
If you miss a dose of Ibrutinib, take it as soon as you remember. If it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
It's generally recommended to avoid or limit alcohol consumption while taking Ibrutinib, as alcohol may increase the risk of certain side effects such as liver toxicity.
Ibrutinib may harm the fetus, so it should not be used during pregnancy unless the potential benefits outweigh the risks. It is also not recommended to breastfeed while taking Ibrutinib, as it may pass into breast milk.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet